Global Trial Accelerators™: Fast-Tracking First-in-Human Trials, Anywhere
Julio G. Martinez-Clark
110 episodes
6 days ago
In this episode, we sit down with David M. Kraemer, Founder of a boutique investment bank and former Vice President at Merrill Lynch and Wilshire Consulting. With deep experience across public and private markets, David shares insights on capital formation, innovation, and navigating complex investment landscapes. From biotech and MedTech to AI, robotics, and venture capital, his perspective bridges finance and technology in today’s fast-changing world. Tune in to hear how he’s built gl...
All content for Global Trial Accelerators™: Fast-Tracking First-in-Human Trials, Anywhere is the property of Julio G. Martinez-Clark and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this episode, we sit down with David M. Kraemer, Founder of a boutique investment bank and former Vice President at Merrill Lynch and Wilshire Consulting. With deep experience across public and private markets, David shares insights on capital formation, innovation, and navigating complex investment landscapes. From biotech and MedTech to AI, robotics, and venture capital, his perspective bridges finance and technology in today’s fast-changing world. Tune in to hear how he’s built gl...
Justin Chickles, CEO & Co-Founder of Glycyx Therapeutics
Global Trial Accelerators™: Fast-Tracking First-in-Human Trials, Anywhere
40 minutes
2 months ago
Justin Chickles, CEO & Co-Founder of Glycyx Therapeutics
Send us a text Could opioids be silently undermining cancer immunotherapy? This week, Justin Chickles — CEO and co-founder of Glycyx Therapeutics — explains how his team is tackling this overlooked challenge with axelopran, a breakthrough therapy now advancing to Phase 2 trials. From his early career at Johnson & Johnson to leading multiple startups, Justin offers a rare, insider’s perspective on driving biotech innovation from concept to clinic. If you’re interested in cutting-edge onc...
Global Trial Accelerators™: Fast-Tracking First-in-Human Trials, Anywhere
In this episode, we sit down with David M. Kraemer, Founder of a boutique investment bank and former Vice President at Merrill Lynch and Wilshire Consulting. With deep experience across public and private markets, David shares insights on capital formation, innovation, and navigating complex investment landscapes. From biotech and MedTech to AI, robotics, and venture capital, his perspective bridges finance and technology in today’s fast-changing world. Tune in to hear how he’s built gl...
